Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02849977 · ClinicalTrials.gov registry record
Genetic Testing and Phenotypic Characterization of Severely Obese Pediatric and Adult Volunteers
A clinical trial, sponsored by Rhythm Pharmaceuticals.
- Completed
- Registry status
- 5,966
- Enrollment target
NCT02849977 is a clinical trial that has completed, run by Rhythm Pharmaceuticals. The registered enrollment target is 5,966 participants.
The verdict
NCT02849977 has completed, sponsored by Rhythm Pharmaceuticals.
- COMPLETED
- Registry status
- 5,966 participants
- Enrollment target
Study Summary
The purpose of this screening study is to identify people who have a rare genetic cause of obesity - specifically three genetic variants (a change in the DNA structure) of the POMC, PCSK1 and LepR genes that are currently known to result in obesity. This screening study will not include any investigational drugs. You will be asked to provide a DNA sample and answer some questions about your medical history and hunger.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,966 participants |
| Start Date | 2016-09-28 |
| Est. Completion | 2020-06-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02849977
The ClinicalTrials.gov registry entry for NCT02849977 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5,966 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rhythm Pharmaceuticals, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02849977 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02849977 about?
NCT02849977 is a clinical study titled "Genetic Testing and Phenotypic Characterization of Severely Obese Pediatric and Adult Volunteers". The purpose of this screening study is to identify people who have a rare genetic cause of obesity - specifically three genetic variants (a change in the DNA structure) of the POMC, PCSK1 and LepR genes that are currently known to result in obesity. This screening study will not include any investi...
What is the current status of trial NCT02849977?
This trial is currently completed. The enrollment target is 5,966 participants. The study started on 2016-09-28. Estimated completion is 2020-06-09.
Who is sponsoring clinical trial NCT02849977?
This trial is sponsored by Rhythm Pharmaceuticals, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.